Democratic candidates take the stage together for the first time as they jockey for position in the race to take on President Trump in 2020.2020 Electionsread more
In a strategy to draw attention away from Wednesday's Democratic debate, President Donald Trump's reelection campaign bought out YouTube's "masthead," the leading...2020 Electionsread more
Virginia Sen. Mark Warner breaks down the idea behind a bipartisan bill he introduced to provide more transparency in Big Tech.Technologyread more
Tesla is working on new battery cell designs, and a way to make their own cells, with R&D teams in a lab near its car plant in Fremont, California.Technologyread more
These attacks have given the public the opportunity to examine the problems associated with ransomware, where corporations -- not obligated to disclose these attacks -- have...Technologyread more
"As a private company we don't have the tools to make the Russian government stop," Facebook CEO Mark Zuckerberg said at the Aspen Ideas Conference on Wednesday. "We can...Technologyread more
Something unusual is happening in financial markets, and it could mean more gains lie ahead for stocks, if history is any indication.Marketsread more
Underneath the impressive market rally is a trend that doesn't seem quite right, according to J.P. Morgan.Marketsread more
Venezuelan President Nicolas Maduro said security forces had foiled an opposition coup attempt that included plans to assassinate him and other top political figures.World Politicsread more
Credit Suisse initiated coverage of Tesla Wednesday with an "underperform" rating and a price target 15% below where the stock closed.Marketsread more
Wi-Fi 6 will be the next-generation wireless standard. Along with 5G, it will represent the next big shift in connectivity and data, said Irving Tan, senior vice president and...Shaping the futureread more
Silicon Valley's medical technology start-ups might have their pick of local investors, but many are now looking further afield to China.
One of the most prolific recent funders on the block is Tencent, the Shenzhen-based internet giant that is best known for its social messaging apps.
In recent years, Tencent has funded a slew of U.S. biotechnology and digital health ventures. According to data from start-up research firms Crunchbase and Rock Health, they include:
The company also invests in more indirect ways.
Tencent led a $155 million round in health and artificial intelligence company iCarbonX, which subsequently secured a $100 million deal with the U.S.-based patient social networking company PatientsLikeMe. The goal for the partnership is to merge various forms of health data, like genomics and patient-reported symptoms, with AI to further our understanding of human disease.
At the time, the companies did not share whether they intended to expand PatientLikeMe's operations to China.
Tencent declined to comment on its investment strategy.
The largest Chinese internet players, Tencent, Baidu and Alibaba all have investment teams in Silicon Valley and other U.S. tech hubs.
But Tencent in particular has set its sights on health care, the U.S.' fifth-largest economy, say people familiar. The company is motivated in part by the health-care problems in China, which include a shortage of doctors and high rates of some cancers.
China is expected to have more than 800,000 lung cancer cases by 2020 on account of pollution and high smoking rates. It also has more people living with Alzheimer's disease than any other country.
"The health-care problems in China are huge," said Ted Driscoll, a Silicon Valley-based medical investor with the Chinese investment firm Decheng Capital. "They (Chinese investors) are interested in any start-ups that have a novel way of dealing with it."
Some of these U.S. companies have not yet expanded to China, but others used the investment to build a presence in the country.
One of Grail's first moves was to merge with a Chinese company called Cirina, founded by notable Chinese scientist Dennis Lo. That deal, if successful, would allow Grail to commercialize its cancer test in both Asian and Western markets.
There's also a huge interest in bringing artificial intelligence to China, with broad support from the government. AI is viewed by policymakers as a tool to replace some of the tasks typically performed by human doctors, so more people can access the treatment they need.
Walter De Brouwer, founder of Scanadu, recalls that technologies like AI were attractive to Tencent's investment team.
"How I see it is that in America, we went from paper to e-health to mobile health to AI health," he said. "In China, they have an opportunity to leapfrog straight from paper to AI."